No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied. Based on metabolism and clearance a clinically significant interaction is unlikely with emtricitabine as rifapentine is deacetylated. Results of an interaction study between tenofovir-DF and rifampicin suggest rifapentine is unlikely to impact tenofovir-DF to a large extent.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking